Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Silva Pharmaceuticals Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	59.43	38.77	38.69	28.64	36.43	58.66
Short-Term Investments	61.84	64.03	88.8	152.72	225.04	211.67
Cash & Short-Term Investments	121.27	102.8	127.49	181.37	261.47	270.33
Cash Growth	-9.20%	-19.37%	-29.70%	-30.64%	-3.28%	12.90%
Accounts Receivable	218.54	229.47	255.72	257.35	255.05	269.91
Other Receivables	0.69	0.14	0.41	1.97	2.56	2.3
Receivables	219.23	229.62	256.13	259.32	257.61	272.21
Inventory	419.21	443.01	493.2	493.72	482.29	464.18
Other Current Assets	50.73	54.4	62.69	66.02	61.79	68.21
Total Current Assets	810.44	829.84	939.52	1,000	1,063	1,075
Property, Plant & Equipment	1,407	1,420	1,473	1,501	1,480	1,371
Other Intangible Assets	2.36	2.42	1.22	1.36	1.51	1.68
Total Assets	2,220	2,252	2,414	2,503	2,545	2,447
Accounts Payable	12.98	9.97	7.16	6.99	6.9	6.25
Accrued Expenses	10.44	9.76	11.85	12.43	16.25	15.28
Short-Term Debt	27.92	28.22	47.71	55.84	91.01	29.14
Current Portion of Leases	1.05	1.07	1.18	1.42	2.34	5.67
Current Income Taxes Payable	7.4	6.47	5.45	7.9	19.03	30.63
Other Current Liabilities	0.14	0.21	0.82	1.62	2.59	1.52
Total Current Liabilities	59.93	55.7	74.16	86.19	138.11	88.48
Long-Term Leases	2.02	2.31	3.44	4.6	5.75	7.9
Long-Term Deferred Tax Liabilities	81.19	81.27	80.68	77.86	75.68	80.3
Total Liabilities	143.13	139.28	158.28	168.65	219.54	176.68
Common Stock	1,365	1,365	1,365	1,365	1,365	1,365
Retained Earnings	712.13	748.04	890.95	969.08	960.2	905.47
Shareholders' Equity	2,077	2,113	2,256	2,334	2,325	2,270
Total Liabilities & Equity	2,220	2,252	2,414	2,503	2,545	2,447
Total Debt	30.99	31.6	52.33	61.86	99.09	42.71
Net Cash (Debt)	90.28	71.21	75.17	119.51	162.38	227.62
Net Cash Growth	12.40%	-5.27%	-37.10%	-26.40%	-28.67%	17.48%
Net Cash Per Share	0.66	0.52	0.55	0.88	1.19	1.67
Filing Date Shares Outstanding	136.5	136.5	136.5	136.5	136.5	136.5
Total Common Shares Outstanding	136.5	136.5	136.5	136.5	136.5	136.5
Working Capital	750.51	774.14	865.35	914.23	925.05	986.45
Book Value Per Share	15.22	15.48	16.53	17.10	17.03	16.63
Tangible Book Value	2,075	2,111	2,255	2,333	2,324	2,269
Tangible Book Value Per Share	15.20	15.46	16.52	17.09	17.02	16.62
Land	342.77	342.77	342.77	342.77	342.77	342.77
Buildings	424.09	424.09	424.09	424.09	424.09	424.09
Machinery	1,149	1,149	1,149	1,090	1,072	998.72
Construction In Progress	323.94	323.28	317.67	343.47	274.25	178.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.